Nasal polyposis-etiology and treatment.
Nasal polyposis is a recurrent disorder requiring numerous surgical polypectomies. Topical nasal steroidal inhalers such as beclomethasone dipropionate (BDP) and flunisolide nasal solution have greatly changed the therapeutic strategy for controlling polypoid formation in the nasal cavities. The judicious use of short courses of oral corticosteroids combined with oral nasal decongestants lessens the need for repeated polypectomies. Nasal douching with normal saline improves nasal ventilation.
D000281:Administration, Intranasal; D000284:Administration, Oral; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001507:Beclomethasone / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D005260:Female; D005446:Fluocinolone Acetonide / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D005938:Glucocorticoids; D006801:Humans; D008297:Male; D014663:Nasal Decongestants / Q000008:administration & dosage / Q000627:therapeutic use; D009298:Nasal Polyps / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D012130:Respiratory Hypersensitivity / Q000150:complications / Q000175:diagnosis; D012141:Respiratory Tract Infections / Q000150:complications; D007507:Therapeutic Irrigation
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D014663:Nasal Decongestants; D005446:Fluocinolone Acetonide; C007734:flunisolide; D001507:Beclomethasone